Tech Company Financing Transactions
Leo Cancer Care Funding Round
Leo Cancer Care closed a $65 million Series D funding round on 7/8/2026. Investors included Yu Galaxy, Eventide Asset Management and private investors.
Transaction Overview
Company Name
Announced On
7/8/2026
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series D
Investors
Yu Galaxy (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Unit 1, Woodbridge House, Chapel Road, Smallfield
Horley, Surrey, RH6 9NW
UK
Horley, Surrey, RH6 9NW
UK
Phone
Website
Email Address
Not Recorded
Overview
Leo Cancer Care was founded with more than 100 years of Radiation Therapy experience by a team dedicated to challenging the norms in everything we do. Patients' lives influence us to find a better way, a better way to improve patient care and how a patient experiences it. A better way to increase the accessibility of cancer treatments for more patients in more places. We believe our technology is that better way. Our family of world class products can provide a streamlined and efficient treatment while making the patient feel in control and hopeful.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Thomas Mackie
Chief Executive Officer
Stephen Towe
Chief Financial Officer
Andy Harley
Chief Scientific Officer
Niek Schreuder
Browse more venture capital transactions:
Prev: 7/8/2026: Hive venture capital transaction
Next: 7/8/2026: Doodhvale Farms venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs